TERF2 gene expression in childhood acute lymphoblastic leukaemia / Lelamekala Vengidasan

Advances in the understanding of cell biology in childhood acute lymphoblastic leukemia (cALL) have led to sophisticated risk-stratification based therapeutic interventions targeting individual patients. Despite these advances, approximately 10-20% of children with ALL still relapse. Thus, identific...

Full description

Bibliographic Details
Main Author: Vengidasan, Lelamekala
Format: Thesis
Published: 2011
Subjects:
Online Access:http://pendeta.um.edu.my/client/default/search/results?qu=TERF2+gene+expression+in+childhood+acute+lymphoblastic+leukaemia&te=
http://studentsrepo.um.edu.my/3832/5/Title_page%2C_abstract%2C_content.pdf
http://studentsrepo.um.edu.my/3832/2/2._Chapter_1_%E2%80%93_6.pdf
http://studentsrepo.um.edu.my/3832/3/3._Appendices.pdf
http://studentsrepo.um.edu.my/3832/4/4._References.pdf
_version_ 1848772508417785856
author Vengidasan, Lelamekala
author_facet Vengidasan, Lelamekala
author_sort Vengidasan, Lelamekala
building UM Research Repository
collection Online Access
description Advances in the understanding of cell biology in childhood acute lymphoblastic leukemia (cALL) have led to sophisticated risk-stratification based therapeutic interventions targeting individual patients. Despite these advances, approximately 10-20% of children with ALL still relapse. Thus, identification of new prognostic indicators will allow for better targeted treatment. TERF2, one of the main components of the shelterin complex (telosome), has been found to be over-expressed in a variety of epithelial malignancies, including lung, skin and breast cancer. This study aims to investigate the level of expression of TERF2 in pediatric ALL and in different cALL patient subgroups and its potential as a prognostic marker in such patients. Diagnostic bone marrow samples were obtained from 72 paediatric patients treated at the University Malaya Medical Centre (UMMC) under the Malaysia-Singapore ALL 2003 study protocol. Expression of TERF2 was measured via real time quantitative PCR using cDNA synthesized from the samples described above. Results were standardized using Β2M transcripts as the internal control and HL60 as the calibrator. Relative quantification of gene expression was calculated by using the delta delta Ct method.
first_indexed 2025-11-14T13:27:38Z
format Thesis
id um-3832
institution University Malaya
institution_category Local University
last_indexed 2025-11-14T13:27:38Z
publishDate 2011
recordtype eprints
repository_type Digital Repository
spelling um-38322013-12-31T09:09:42Z TERF2 gene expression in childhood acute lymphoblastic leukaemia / Lelamekala Vengidasan Vengidasan, Lelamekala QH301 Biology Advances in the understanding of cell biology in childhood acute lymphoblastic leukemia (cALL) have led to sophisticated risk-stratification based therapeutic interventions targeting individual patients. Despite these advances, approximately 10-20% of children with ALL still relapse. Thus, identification of new prognostic indicators will allow for better targeted treatment. TERF2, one of the main components of the shelterin complex (telosome), has been found to be over-expressed in a variety of epithelial malignancies, including lung, skin and breast cancer. This study aims to investigate the level of expression of TERF2 in pediatric ALL and in different cALL patient subgroups and its potential as a prognostic marker in such patients. Diagnostic bone marrow samples were obtained from 72 paediatric patients treated at the University Malaya Medical Centre (UMMC) under the Malaysia-Singapore ALL 2003 study protocol. Expression of TERF2 was measured via real time quantitative PCR using cDNA synthesized from the samples described above. Results were standardized using Β2M transcripts as the internal control and HL60 as the calibrator. Relative quantification of gene expression was calculated by using the delta delta Ct method. 2011 Thesis NonPeerReviewed application/pdf http://studentsrepo.um.edu.my/3832/5/Title_page%2C_abstract%2C_content.pdf application/pdf http://studentsrepo.um.edu.my/3832/2/2._Chapter_1_%E2%80%93_6.pdf application/pdf http://studentsrepo.um.edu.my/3832/3/3._Appendices.pdf application/pdf http://studentsrepo.um.edu.my/3832/4/4._References.pdf http://pendeta.um.edu.my/client/default/search/results?qu=TERF2+gene+expression+in+childhood+acute+lymphoblastic+leukaemia&te= Vengidasan, Lelamekala (2011) TERF2 gene expression in childhood acute lymphoblastic leukaemia / Lelamekala Vengidasan. Masters thesis, University of Malaya. http://studentsrepo.um.edu.my/3832/
spellingShingle QH301 Biology
Vengidasan, Lelamekala
TERF2 gene expression in childhood acute lymphoblastic leukaemia / Lelamekala Vengidasan
title TERF2 gene expression in childhood acute lymphoblastic leukaemia / Lelamekala Vengidasan
title_full TERF2 gene expression in childhood acute lymphoblastic leukaemia / Lelamekala Vengidasan
title_fullStr TERF2 gene expression in childhood acute lymphoblastic leukaemia / Lelamekala Vengidasan
title_full_unstemmed TERF2 gene expression in childhood acute lymphoblastic leukaemia / Lelamekala Vengidasan
title_short TERF2 gene expression in childhood acute lymphoblastic leukaemia / Lelamekala Vengidasan
title_sort terf2 gene expression in childhood acute lymphoblastic leukaemia / lelamekala vengidasan
topic QH301 Biology
url http://pendeta.um.edu.my/client/default/search/results?qu=TERF2+gene+expression+in+childhood+acute+lymphoblastic+leukaemia&te=
http://pendeta.um.edu.my/client/default/search/results?qu=TERF2+gene+expression+in+childhood+acute+lymphoblastic+leukaemia&te=
http://studentsrepo.um.edu.my/3832/5/Title_page%2C_abstract%2C_content.pdf
http://studentsrepo.um.edu.my/3832/2/2._Chapter_1_%E2%80%93_6.pdf
http://studentsrepo.um.edu.my/3832/3/3._Appendices.pdf
http://studentsrepo.um.edu.my/3832/4/4._References.pdf